• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泼尼松和泼尼松龙放射免疫分析方法的开发及其在泼尼松肝脏代谢研究中的应用。

Development of radioimmunoassays for prednisone and prednisolone. Application to studies of hepatic metabolism of prednisone.

作者信息

Schalm S W, Summerskill W H, Go V L

出版信息

Mayo Clin Proc. 1976 Dec;51(12):761-6.

PMID:994553
Abstract

Radioimmunoassays for measuring prednisone and prednisolone (delta1 corticosteroids) in serum have been developed. By using 6,7-3H-delta1 corticosteroids as tracer, rabbit antibodies against delta1 corticosteroid-21-hemisuccinate in bovine serum albumin, and ammonium sulfate precipitation, the assays detected less than 0.8 ng/ml of delta1 corticosteroid and interassay coefficients of variation were less than 8.5 %. The specificity of antibodies, tested against all drug metabolites and major endogenous steroids, showed that only 21-glucuronic acid esters of delta1 corticosteroids had cross-reactivity of possible clinical importance. Assays were validated by measuring levels in samples of fastingstate sera with or without adding known amounts of prednisolone. Measurements of serum concentrations of both prednisone and prednisolone in normal dogs and in those with hepatic vascular exclusion were made after intravenous administration of prednisone. Although high levels of prednisolone appeared rapidly in normal dogs, only slight amounts were measured in dogs with hepatic vascular exclusion, which emphasized the importance of the liver in the conversion of prednisone to prednisolone, its active metabolite.

摘要

已开发出用于测定血清中泼尼松和泼尼松龙(δ1皮质类固醇)的放射免疫测定法。通过使用6,7-3H-δ1皮质类固醇作为示踪剂、针对牛血清白蛋白中δ1皮质类固醇-21-半琥珀酸酯的兔抗体以及硫酸铵沉淀法,该测定法可检测到低于0.8 ng/ml的δ1皮质类固醇,测定间变异系数小于8.5%。针对所有药物代谢物和主要内源性类固醇进行测试的抗体特异性表明,只有δ1皮质类固醇的21-葡萄糖醛酸酯具有可能具有临床重要性的交叉反应性。通过测量添加或不添加已知量泼尼松龙的空腹状态血清样本中的水平来验证测定法。在静脉注射泼尼松后,对正常犬和肝血管阻断犬的血清泼尼松和泼尼松龙浓度进行了测量。尽管正常犬体内迅速出现高浓度的泼尼松龙,但在肝血管阻断犬中仅检测到少量,这强调了肝脏在将泼尼松转化为其活性代谢物泼尼松龙过程中的重要性。

相似文献

1
Development of radioimmunoassays for prednisone and prednisolone. Application to studies of hepatic metabolism of prednisone.泼尼松和泼尼松龙放射免疫分析方法的开发及其在泼尼松肝脏代谢研究中的应用。
Mayo Clin Proc. 1976 Dec;51(12):761-6.
2
Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.用新型放射免疫分析法研究泼尼松龙与泼尼松的动力学及相互转化。
J Clin Endocrinol Metab. 1975 Oct;41(4):717-21. doi: 10.1210/jcem-41-4-717.
3
Distribution and metabolism of prednisone in mice, dogs, and monkeys.泼尼松在小鼠、狗和猴子体内的分布与代谢。
Cancer Treat Rep. 1977 Oct;61(7):1279-89.
4
Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.泼尼松用于慢性活动性肝病:药代动力学,包括向泼尼松龙的转化。
Gastroenterology. 1977 May;72(5 Pt 1):910-3.
5
Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver disease.
Clin Pharmacokinet. 1982 Sep-Oct;7(5):452-9. doi: 10.2165/00003088-198207050-00005.
6
Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.
J Pharm Sci. 1976 Jul;65(7):997-1001. doi: 10.1002/jps.2600650711.
7
Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.肝脏疾病中的皮质类固醇:关于泼尼松向泼尼松龙的生物转化及血浆蛋白结合的研究
Gut. 1972 Sep;13(9):690-6. doi: 10.1136/gut.13.9.690.
8
Radioimmunoassay for prednisone.泼尼松的放射免疫测定法
Steroids. 1974 Jul;24(1):95-106. doi: 10.1016/0039-128x(74)90048-8.
9
Determination of prednisone and prednisolone in human serum by high-performance liquid chromatography--especially on impaired conversion of corticosteroids in patients with chronic liver disease.
J Chromatogr. 1982 Apr 30;239:711-6. doi: 10.1016/s0021-9673(00)82030-0.
10
Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone.抗酸剂与泼尼松同时给药:对泼尼松龙血清水平的影响。
Br J Clin Pharmacol. 1979 Apr;7(4):397-400. doi: 10.1111/j.1365-2125.1979.tb00952.x.

引用本文的文献

1
Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver disease.
Clin Pharmacokinet. 1982 Sep-Oct;7(5):452-9. doi: 10.2165/00003088-198207050-00005.
2
Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.泼尼松和泼尼松龙在健康志愿者和患者中的药代动力学及生物利用度:综述
J Pharmacokinet Biopharm. 1980 Feb;8(1):1-52. doi: 10.1007/BF01059447.
3
Relative immunosuppressive potency of various corticosteroids measured in vitro.体外测量的各种皮质类固醇的相对免疫抑制效力。
Eur J Clin Pharmacol. 1983;25(4):459-62. doi: 10.1007/BF00542111.
4
Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.口服泼尼松治疗慢性活动性肝病:剂量反应及生物利用度研究。
Gut. 1978 Dec;19(12):1131-5. doi: 10.1136/gut.19.12.1131.
5
Corticosteroid pharmacokinetics in liver disease.
Clin Pharmacokinet. 1979 May-Jun;4(3):233-40. doi: 10.2165/00003088-197904030-00005.